Lexicon Pharmaceuticals | Betriebsergebnis

Aktienkurs
1.31
Täglich Wechseln
0 0%
Monatlich
5.65%
Jährlich
66.90%
Q1 Prognose
2.01




Betriebsergebnis Veränderung Datum
Abbott USD 2.25B 73M 2025-12
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Coherus Biosciences USD -45.43M 3.13M 2025-03
Eli Lilly USD 8.99B 599.9M 2025-12
Esperion Therapeutics USD -16.03M 18.6M 2024-09
Halozyme Therapeutics USD 217.92M 15.48M 2025-09
Illumina USD 256M 6M 2025-12
Insmed USD -261.35M 7.48M 2025-09
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 5.59B 1.81B 2025-12
Lexicon Pharmaceuticals USD -55.35M 10.02M 2024-06
MacroGenics USD 18.64M 55.4M 2025-09
MannKind USD -41.05M 2.36M 2025-09
Merck USD 6.24B 318M 2025-12
Moderna USD -857M 597M 2025-12
Novartis USD 4.5B 363M 2025-09
PTC Therapeutics USD 3.49M 38.35M 2025-09
Puma Biotechnology USD 22.08M 24.26M 2024-09
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD 389.3M 112.4M 2025-09
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12


Lexicon Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.